Heregulin-β1-induced GPR30 upregulation promotes the migration and invasion potential of SkBr3 breast cancer cells via ErbB2/ErbB3–MAPK/ERK pathway (Q39378293)

From Wikidata

Jump to navigation Jump to search

scientific article published on March 8, 2012

Language	Label	Description	Also known as
English	Heregulin-β1-induced GPR30 upregulation promotes the migration and invasion potential of SkBr3 breast cancer cells via ErbB2/ErbB3–MAPK/ERK pathway	scientific article published on March 8, 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Heregulin-β1-induced GPR30 upregulation promotes the migration and invasion potential of SkBr3 breast cancer cells via ErbB2/ErbB3-MAPK/ERK pathway (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Heregulin-β1-induced GPR30 upregulation promotes the migration and invasion potential of SkBr3 breast cancer cells via ErbB2/ErbB3–MAPK/ERK pathway (English)

1 reference

10.1016/J.BBRC.2012.03.004

https://api.crossref.org/works/10.1016/J.BBRC.2012.03.004

27 December 2024

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22425775

27 December 2024

author name string

Shu-Qin Ruan

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Zhan-Huai Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Shan-Wei Wang

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Zhi-Xuan Fu

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Kan-Lun Xu

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Dong-Bo Li

6

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Su-Zhan Zhang

7

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

language of work or name

0 references

publication date

8 March 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0006291X12004421?httpAccept=text/xml

1 reference

10.1016/J.BBRC.2012.03.004

https://api.crossref.org/works/10.1016/J.BBRC.2012.03.004

27 December 2024

https://api.elsevier.com/content/article/PII:S0006291X12004421?httpAccept=text/plain

1 reference

10.1016/J.BBRC.2012.03.004

https://api.crossref.org/works/10.1016/J.BBRC.2012.03.004

27 December 2024

Biochemical and Biophysical Research Communications

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

420

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

385-390

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Molecular portraits of human breast tumours

1

1 reference

10.1016/J.BBRC.2012.03.004

https://api.crossref.org/works/10.1016/J.BBRC.2012.03.004

27 December 2024

Update on endocrine therapy for breast cancer

2

1 reference

10.1016/J.BBRC.2012.03.004

https://api.crossref.org/works/10.1016/J.BBRC.2012.03.004

27 December 2024

GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release

3

1 reference

10.1016/J.BBRC.2012.03.004

https://api.crossref.org/works/10.1016/J.BBRC.2012.03.004

27 December 2024

Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF

4

1 reference

10.1016/J.BBRC.2012.03.004

https://api.crossref.org/works/10.1016/J.BBRC.2012.03.004

27 December 2024

GPR30: a novel therapeutic target in estrogen-related disease

5

1 reference

10.1016/J.BBRC.2012.03.004

https://api.crossref.org/works/10.1016/J.BBRC.2012.03.004

27 December 2024

Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression

6

1 reference

10.1016/J.BBRC.2012.03.004

https://api.crossref.org/works/10.1016/J.BBRC.2012.03.004

27 December 2024

Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF

7

1 reference

10.1016/J.BBRC.2012.03.004

https://api.crossref.org/works/10.1016/J.BBRC.2012.03.004

27 December 2024

Estrogen and HER-2 Receptor Discordance Between Primary Breast Cancer and Metastasis

8

1 reference

10.1016/J.BBRC.2012.03.004

https://api.crossref.org/works/10.1016/J.BBRC.2012.03.004

27 December 2024

Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients

9

1 reference

10.1016/J.BBRC.2012.03.004

https://api.crossref.org/works/10.1016/J.BBRC.2012.03.004

27 December 2024

Breast cancer heterogeneity: mechanisms, proofs, and implications

10

1 reference

10.1016/J.BBRC.2012.03.004

https://api.crossref.org/works/10.1016/J.BBRC.2012.03.004

27 December 2024

Neuregulins: functions, forms, and signaling strategies

11

1 reference

10.1016/J.BBRC.2012.03.004

https://api.crossref.org/works/10.1016/J.BBRC.2012.03.004

27 December 2024

Bidirectional interactions between the estrogen receptor and the cerbB-2 signaling pathways: heregulin inhibits estrogenic effects in breast cancer cells

13

1 reference

10.1016/J.BBRC.2012.03.004

https://api.crossref.org/works/10.1016/J.BBRC.2012.03.004

27 December 2024

Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells

15

1 reference

10.1016/J.BBRC.2012.03.004

https://api.crossref.org/works/10.1016/J.BBRC.2012.03.004

27 December 2024

G protein-coupled receptor 30 expression is up-regulated by EGF and TGF alpha in estrogen receptor alpha-positive cancer cells

16

1 reference

10.1016/J.BBRC.2012.03.004

https://api.crossref.org/works/10.1016/J.BBRC.2012.03.004

27 December 2024

Identification of genes induced by neuregulin in cultured myotubes

17

1 reference

10.1016/J.BBRC.2012.03.004

https://api.crossref.org/works/10.1016/J.BBRC.2012.03.004

27 December 2024

P2Y2 nucleotide receptors mediate metalloprotease-dependent phosphorylation of epidermal growth factor receptor and ErbB3 in human salivary gland cells

18

1 reference

10.1016/J.BBRC.2012.03.004

https://api.crossref.org/works/10.1016/J.BBRC.2012.03.004

27 December 2024

Studies on the structure and function of glycosylated and nonglycosylated neu differentiation factors. Similarities and differences of the alpha and beta isoforms

19

1 reference

10.1016/J.BBRC.2012.03.004

https://api.crossref.org/works/10.1016/J.BBRC.2012.03.004

27 December 2024

The G protein-coupled receptor 30 is up-regulated by hypoxia-inducible factor-1alpha (HIF-1alpha) in breast cancer cells and cardiomyocytes

21

1 reference

10.1016/J.BBRC.2012.03.004

https://api.crossref.org/works/10.1016/J.BBRC.2012.03.004

27 December 2024

The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin

22

1 reference

10.1016/J.BBRC.2012.03.004

https://api.crossref.org/works/10.1016/J.BBRC.2012.03.004

27 December 2024

Expression of c-erbB receptors, heregulin and oestrogen receptor in human breast cell lines

23

1 reference

10.1016/J.BBRC.2012.03.004

https://api.crossref.org/works/10.1016/J.BBRC.2012.03.004

27 December 2024

Role of heregulin in human cancer

24

1 reference

10.1016/J.BBRC.2012.03.004

https://api.crossref.org/works/10.1016/J.BBRC.2012.03.004

27 December 2024

Novel anticancer targets: revisiting ERBB2 and discovering ERBB3.

25

1 reference

10.1016/J.BBRC.2012.03.004

https://api.crossref.org/works/10.1016/J.BBRC.2012.03.004

27 December 2024

The β2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells

26

1 reference

10.1016/J.BBRC.2012.03.004

https://api.crossref.org/works/10.1016/J.BBRC.2012.03.004

27 December 2024

Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells

28

1 reference

10.1016/J.BBRC.2012.03.004

https://api.crossref.org/works/10.1016/J.BBRC.2012.03.004

27 December 2024

GPR30: a novel indicator of poor survival for endometrial carcinoma

29

1 reference

10.1016/J.BBRC.2012.03.004

https://api.crossref.org/works/10.1016/J.BBRC.2012.03.004

27 December 2024

G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer

30

1 reference

10.1016/J.BBRC.2012.03.004

https://api.crossref.org/works/10.1016/J.BBRC.2012.03.004

27 December 2024

Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients

31

1 reference

10.1016/J.BBRC.2012.03.004

https://api.crossref.org/works/10.1016/J.BBRC.2012.03.004

27 December 2024

Identifiers

10.1016/J.BBRC.2012.03.004

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39378293&oldid=2291790130"